I agree with Baldwin's comments. The FDA could well have stated we only need to replicate P2 when NEU/Acadia was designing the P3 trial but when push comes to shove for the FDA to vote on the NDA you dont know what will happen. In saying that it will come down to the results and also the fact this is treating a condition which currently has nothing so the advocacy groups would push hard for approval in my opinion.
Not long to go now.
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-155
-
- There are more pages in this discussion • 10,792 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.82 |
Change
-0.050(0.24%) |
Mkt cap ! $2.671B |
Open | High | Low | Value | Volume |
$20.96 | $21.28 | $20.71 | $2.660M | 126.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 173 | $20.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.82 | 73 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 103 | 20.790 |
5 | 453 | 20.780 |
10 | 995 | 20.770 |
3 | 252 | 20.760 |
5 | 1479 | 20.750 |
Price($) | Vol. | No. |
---|---|---|
20.800 | 5 | 3 |
20.810 | 324 | 9 |
20.820 | 510 | 9 |
20.830 | 515 | 7 |
20.840 | 249 | 3 |
Last trade - 15.04pm 24/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online